R B Strutyns'kyĭ Selected Research

Fluorine

1/2013	[Biochemical mechanisms of the cardioprotective effect of the K(ATP) channels opener flocalin (medicinal form) in ischemia-reperfusion of myocardium].
1/2012	[The changes of metabolism in myocardium at ischemia-reperfusion and activating of the ATP-sensitive potassium channels].
1/2011	[Effect of medical form of flocalin on the course of myocardial reperfusion injury].
1/2010	[Effect of a new activator of adenosine triphosphate-sensitive potassium channels flocalin on the glucose level in blood].
1/2009	[Cardioprotective effects of fluorine-containing activator of adenosine triphosphate-dependent potassium channels flokalin].
1/2009	[Cardioprotective effects of activation of ATP-sensitive potassium channels in experiments in vivo: influence on blood biochemical parameters following ischemia-reperfusion of the myocardium].
1/2009	[Cardioprotective effects of flokalin in experiments in vivo: influence on hemodynamic and myocardial lesions in ischemia-reperfusion].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R B Strutyns'kyĭ Research Topics

Disease

10	Ischemia 01/2013 - 01/2001
4	Infarction (Infarctions) 01/2011 - 01/2009
2	Necrosis 01/2013 - 01/2012
2	Body Weight (Weight, Body) 01/2009 - 01/2009
1	Hypoxia (Hypoxemia) 01/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013
1	Myocardial Reperfusion Injury 01/2011
1	Premature Cardiac Complexes (Extrasystoles) 01/2005
1	Diabetes Mellitus 01/2003

Drug/Important Bio-Agent (IBA)

11	N- (4- difluoromethoxyphenyl)- N'- pinacolyl- N''- cyanoguanidineIBA 01/2013 - 01/2005
8	Adenosine Triphosphate (ATP)IBA 01/2013 - 01/2001
7	FluorineIBA 01/2013 - 01/2009
6	KATP ChannelsIBA 01/2013 - 01/2003
4	TabletsIBA 01/2013 - 01/2010
3	PotassiumIBA 01/2013 - 01/2009
2	Superoxides (Superoxide)IBA 01/2013 - 01/2009
2	Mitochondrial Permeability Transition PoreIBA 01/2013 - 01/2012
2	Peroxynitrous Acid (Peroxynitrite)IBA 01/2012 - 01/2009
1	CalciumIBA 01/2013
1	Leukotriene C4IBA 01/2013
1	Potassium Channels (Potassium Channel)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013
1	Heme (Haem)IBA 01/2012
1	Guanosine Triphosphate (GTP)IBA 01/2012
1	NAD (NADH)IBA 01/2012
1	EicosanoidsIBA 01/2012
1	Arachidonic Acid (Vitamin F)IBA 01/2012
1	Arginine (L-Arginine)FDA Link 01/2012
1	ArginaseIBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2010
1	Phosphorus (Red Phosphorus)IBA 01/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009
1	Uric Acid (Urate)IBA 01/2009
1	Streptozocin (Streptozotocin)FDA Link 01/2003

Therapy/Procedure

2	Catheters 01/2011 - 01/2010